Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162403
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-11-30
Brief Title:
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy A Longitudinal Single Center Feasibility Study
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Study Overview
Official Title:
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy A Longitudinal Single Center Feasibility Study
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To learn if peripheral nerve stimulation PNS can help to improve pain in participants with CIPN
Detailed Description:
Primary objective
To assess Pain intensity NRS scores in chemotherapy induced peripheral neuropathy CIPN participants before and after use of peripheral nerve stimulation PNS
Secondary objectives
To assess changes in quantitative sensory testing QST gait testing and skin punch biopsy to compare the integrity of Meissners corpuscles MC pain disability using the Oswestry Disability Index ODI pain interference using the Brief Pain Inventory BPI and Patient Global Impression of Change PGIC in CIPN patients before and after use of PNS
To assess Pain intensity NRS scores in chemotherapy induced peripheral neuropathy CIPN participants before and after use of peripheral nerve stimulation PNS
Secondary objectives
To assess changes in quantitative sensory testing QST gait testing and skin punch biopsy to compare the integrity of Meissners corpuscles MC pain disability using the Oswestry Disability Index ODI pain interference using the Brief Pain Inventory BPI and Patient Global Impression of Change PGIC in CIPN patients before and after use of PNS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2023-10303 | OTHER | NCI-2023-10303 | None |